Ovid Therapeutics Inc (NASDAQ:OVID). shares have tumbled to a 52-week low, with the stock price hitting $0.59, marking a stark contrast to its performance over the past year. According to InvestingPro ...
A recent exhibition at Delhi’s Vadehra Art Gallery showcased the multi-hyphenate Gieve Patel’s artworks alongside works by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback